(Q43279489)
Statements
Randomized, placebo-controlled, phase II study of sequential erlotinib and chemotherapy as first-line treatment for advanced non-small-cell lung cancer (English)
Caicun Zhou
Yuh-Min Chen
Li Zhang
Jorge Ignacio
Meilin Liao
Vichien Srimuninnimit
Marina Chua-Tan
Virote Sriuranpong
Aru W Sudoyo
Kate Jin
Michael Johnston
Winsome Chui
8 September 2009